DeepMed Research

NSAID

Generic Name: NSAID

Clinical Trials

NSAID Treatment of Patients With Osteoarthritis

Not Applicable

Completed

Conditions: Osteoarthritis,Knee

Interventions: Drug: NSAID

First Posted Date: 2016-11-18

Last Posted Date: 2024-02-22

Lead Sponsor: Aalborg University

Target Recruit Count: 162

Registration Number: NCT02967744

Locations: 🇩🇰
Center for Sensory Motor Interaction, Aalborg University, Aalborg East, Denmark

NSAID Use in Postpartum Hypertensive Women

Phase 4

Terminated

Conditions: Hypertension

Interventions: Drug: Acetaminophen
Drug: NSAID

First Posted Date: 2016-09-15

Last Posted Date: 2018-10-31

Lead Sponsor: St. Louis University

Target Recruit Count: 36

Registration Number: NCT02902172

Locations: 🇺🇸
St. Mary's Health Center, Saint Louis, Missouri, United States

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Phase 3

Completed

Conditions: Chronic Pain
Osteoarthritis, Hip
Osteoarthritis, Knee

Interventions: Drug: NSAID
Biological: Tanezumab 2.5 mg
Biological: Tanezumab 5 mg

First Posted Date: 2015-08-19

Last Posted Date: 2020-01-10

Lead Sponsor: Pfizer

Target Recruit Count: 3021

Registration Number: NCT02528188

Locations: 🇺🇸
Chicago Clinical Research Institute Inc., Chicago, Illinois, United States
🇺🇸
Northwestern Memorial Hospital-Arkes Pavilion, Diagnostic Testing Center, Chicago, Illinois, United States
🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

and more 482 locations

Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis

Phase 3

Completed

Conditions: Osteoarthritis

Interventions: Drug: Meloxicam
Drug: NSAID

First Posted Date: 2014-07-08

Last Posted Date: 2014-07-08

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 1309

Registration Number: NCT02183064

Operative Treatment of Unstable Thoracic Cage Injuries and Chest Wall Deformity in Trauma

Not Applicable

Completed

Conditions: Surgery
Trauma
Flail Chest
Rib Fractures

Interventions: Drug: NSAID
Drug: Opioids
Drug: Thoracic Epidural anaesthesia
Drug: Paracetamol
Procedure: Surgical management

First Posted Date: 2014-05-07

Last Posted Date: 2019-01-16

Lead Sponsor: Sahlgrenska University Hospital, Sweden

Target Recruit Count: 92

Registration Number: NCT02132416

Locations: 🇸🇪
Departement of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
🇸🇪
Departement of Intensive Care, Karolinska University Hospital, Stockholm, Sweden

Pain as Indication for Operative Treatment of Traumatic Rib Fractures

Not Applicable

Withdrawn

Conditions: Trauma
Rib Fractures
Surgery
Pain

Interventions: Drug: NSAID
Procedure: thoracic epidural anesthesia
Drug: opioids
Drug: paracetamol
Procedure: operative fixation of rib fractures

First Posted Date: 2014-03-24

Last Posted Date: 2018-07-12

Lead Sponsor: Sahlgrenska University Hospital, Sweden

Registration Number: NCT02094807

Locations: 🇸🇪
Sahlgrenska University Hospital, Gothenburg, Sweden

Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

Phase 2

Completed

Conditions: Patent Ductus Arteriosus
Necrotizing Enterocolitis
Surgery
Intestinal Perforation

Interventions: Other: pharmacologic treatment of the PDA
Other: no pharmacologic treatment of the PDA
Drug: NSAID

First Posted Date: 2013-10-09

Last Posted Date: 2018-11-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 202

Registration Number: NCT01958320

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇸🇪
University Hospital, Umea, Sweden, Umea, Sweden
🇹🇷
Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey

and more 15 locations

Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)

Phase 3

Completed

Conditions: Orthopaedic Fractures

Interventions: Drug: placebo
Drug: Gabapentinoids
Drug: NSAID

First Posted Date: 2013-02-12

Last Posted Date: 2021-02-03

Lead Sponsor: Major Extremity Trauma Research Consortium

Target Recruit Count: 450

Registration Number: NCT01789216

Locations: 🇺🇸
University of Maryland, R Adams Cowley Shock Trauma Center, Baltimore, Maryland, United States
🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Carolinas Medical Center, Charlotte, North Carolina, United States

and more 14 locations

Oral Contraceptive During Menopausal Transition

Not Applicable

Conditions: Perimenopause

Interventions: Drug: oral contraceptive
Drug: NSAID

First Posted Date: 2011-08-11

Last Posted Date: 2013-09-10

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 52

Registration Number: NCT01414530

Locations: 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of

Paracetamol and Patent Ductus Arteriosus (PDA)

Phase 2

Conditions: Patent Ductus Arteriosus

Interventions: Drug: Paracetamol
Drug: NSAID
Drug: D5W

First Posted Date: 2011-02-08

Last Posted Date: 2012-12-19

Lead Sponsor: Shaare Zedek Medical Center

Target Recruit Count: 80

Registration Number: NCT01291654

Locations: 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy